Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market
Holding KYMR?
Track your performance easily

Kymera Therapeutics (KYMR) Financial Statements

203 Followers

Kymera Therapeutics Financial Overview

Kymera Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.328; its P/E ratio is -20.48; Kymera Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 3.74M$ 25.65M$ 10.29M$ 47.88M$ 4.73M
Gross Profit$ 3.74M$ 25.65M$ 10.29M$ 47.88M$ 4.73M
EBIT$ -62.44M$ -42.02M$ -48.51M$ -14.32M$ -52.83M
EBITDA$ -60.45M$ -40.08M$ -47.05M$ -13.43M$ -51.94M
Net Income Common Stockholders$ -62.49M$ -42.06M$ -48.56M$ -14.37M$ -52.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 549.97M$ 509.95M$ 520.54M$ 374.88M$ 357.82M
Total Assets$ 1.03B$ 826.02M$ 868.25M$ 575.76M$ 552.38M
Total Debt$ 88.23M$ 88.18M$ 87.02M$ 84.67M$ 80.84M
Net Debt$ -461.74M$ -421.77M$ -433.52M$ -290.21M$ -276.98M
Total Liabilities$ 141.91M$ 141.10M$ 157.05M$ 180.79M$ 156.84M
Stockholders Equity$ 892.93M$ 684.89M$ 711.20M$ 394.97M$ 395.54M
Cash Flow-
Free Cash Flow$ -50.00M$ -47.63M$ -46.99M$ -3.58M$ -39.73M
Operating Cash Flow$ -50.19M$ -42.94M$ -39.59M$ 8.04M$ -31.65M
Investing Cash Flow$ -157.68M$ 15.64M$ -330.61M$ 18.95M$ 60.51M
Financing Cash Flow$ 250.92M$ 1.41M$ 353.76M$ 1.93M$ -206.00K
Currency in USD

Kymera Therapeutics Earnings and Revenue History

Kymera Therapeutics Debt to Assets

Kymera Therapeutics Cash Flow

Kymera Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis